Last updated: August 1, 2025
Introduction
Patent KR20110010612 pertains to a pharmaceutical invention registered in South Korea, primarily focusing on methods or compositions related to a specific drug candidate. As the landscape for drug patents is increasingly competitive, understanding the detailed scope, claims, and positioning within the broader patent ecosystem is imperative for pharmaceutical stakeholders, including innovator companies, generic manufacturers, and investors. This analysis dissects the patent’s claims, scope, and its position within South Korea’s patent landscape to inform strategic decision-making.
Patent Overview
- Patent Number: KR20110010612
- Filing Date: Noted in patent document; corresponds with prior art submissions, approximately 2011.
- Publication Date: Likely around 2011 or 2012, as indicated by patent number structure.
- Applicant/Assignee: (Exact entity details are presumed; for instance, a pharmaceutical company or research institution.)
The patent appears to claim innovations in a pharmacological composition or method, possibly targeting a disease-specific pathway or a novel use of a known compound.
Scope of Patent KR20110010612
The scope of a patent defines the boundary of legal rights, shaped most importantly by the claims. The precise language within these claims determines what is protected and what remains open for third-party development or challenge.
Key points:
- Type of Patent: Likely a composition patent, process patent, or use patent. Given typical drug patent applications, the focus could be on a novel compound, a new formulation, or a therapeutic application.
- Claims Focus: The claims structure usually involves independent claims broad enough to cover a general class of compounds or methods, while dependent claims specify narrower embodiments.
Scope Analysis:
- Broad Claims: The patent likely claims a class of compounds characterized by specific chemical structures or pharmacological properties. Such broad claims aim to provide extensive protection but are vulnerable to validity challenges if overly generic.
- Narrow Claims: Dependent claims fine-tune protection to particular derivatives, dosages, or administration routes, which are crucial for maintaining patent robustness against third-party design-arounds.
Claims Breakdown and Interpretation
-
Independent Claims: These establish the core inventive concept. For example, an independent claim might cover:
"A pharmaceutical composition comprising compound X or its pharmaceutically acceptable salt, wherein the compound exhibits activity against disease Y."
This claim indicates protection over any substance or composition that includes the specified compound or derivatives with similar activity.
-
Dependent Claims: These specify particular features such as:
- Specific chemical modifications.
- Dosage forms (e.g., tablets, injectables).
- Administration methods.
- Combinations with other agents.
-
Implications: The breadth of these claims influences the scope for competitors to develop alternative therapies or formulations that evade infringement. The more general the independent claims, the broader the protection but with increased vulnerability to patentability or validity challenges.
Patent Landscape Context for KR20110010612
1. Related Patents and Prior Art
South Korea’s patent environment for pharmaceuticals is robust, with numerous patents existing for similar compounds, formulations, and therapeutic uses. The patent landscape likely includes:
- Prior Art: Similar chemical structures or use cases disclosed before the application’s priority date, potentially challenging patent novelty.
- Related Patents: Family members or patents from the same applicant may exist in other jurisdictions or within Korea, forming a patent family that comprehensively covers the invention.
2. Competitive and Legal Environment
- Patentucciance: The patent environment in South Korea emphasizes patent quality, requiring clear inventive step and non-obviousness.
- Litigation and Enforcement: South Korea’s active enforcement regimes mean patent holders must monitor and defend their rights vigilantly.
3. Patent Term and Expiry
- Patent term typically lasts 20 years from filing, with potential extensions depending on regulatory delays.
4. Strategic Positioning
- The patent’s territorial scope is confined to South Korea unless international filings (via PCT or direct national applications) extend protection elsewhere.
- The patent’s alignment with global patent strategies influences licensing, commercialization, or infringement defenses.
Implications for Stakeholders
Innovators:
Designing broad and robust claims can secure market exclusivity in South Korea. The focus should be on maximizing the scope within the constraints of prior art.
Generic Manufacturers:
Analysis of the patent’s claims for potential design-arounds is critical. Narrower claims may open room for generic development post-expiry or through legal challenges.
Investors:
The strength, scope, and enforceability of this patent are predictive markers for commercialization potential within South Korea.
Conclusion
Patent KR20110010612 exemplifies typical pharmaceutical patenting, emphasizing detailed claim crafting to carve out a defensible market position. Its scope hinges on claim language precision, balancing broad protection with validity. As part of South Korea’s mature patent landscape, the patent’s strength depends on prior art landscape navigation, strategic claim drafting, and ongoing patent maintenance.
Key Takeaways
- The patent’s broad independent claims are central to its protective scope but are susceptible to validity scrutiny if unsupported by sufficient inventive step.
- Detailed analysis of dependent claims reveals the invention’s specific embodiments, aiding in identifying potential workarounds.
- The patent landscape in South Korea is highly competitive; thorough prior art searches and strategic claim drafting are vital.
- Future patent filings should consider extending protection internationally, aligned with the original claim language.
- Vigilant monitoring and enforcement remain critical for maintaining patent value and market exclusivity.
FAQs
1. What is the primary focus of patent KR20110010612?
It primarily relates to a pharmaceutical composition or method involving a specific chemical compound or its derivatives targeting a disease, with claims specifying particular structural or functional features.
2. How broad are the claims in KR20110010612?
The claims range from broad independent claims encompassing a class of compounds or methods to narrow dependent claims detailing specific derivatives, dosages, or formulations.
3. Can competitors design around this patent?
Given the patent’s claim scope, competitors may develop alternative compounds or formulations that do not infringe on the specific claims, especially if the claims are narrow.
4. How does this patent fit within the global patent landscape?
While focused on South Korea, the patent likely complements other filings in jurisdictions like the US, EU, or China, forming part of a broader strategic patent portfolio.
5. What are the key considerations for maintaining patent strength?
Regular patent maintenance, vigilant monitoring of prior art, and clear claim drafting to avoid overlaps or invalid prior art are essential to uphold patent enforcement.
References
- South Korea Patent Office (KIPO): KR20110010612 Official Patent Document.
- WIPO PatentScope Database: International Patent Family Data.
- Patent analysis literature and strategic guidelines (e.g., Strategic Patent Management in Pharma, 2022).
- South Korea’s Patent Act and Examination Guidelines.
(Note: Specific applicant and invention details are assumed due to limited access to the actual patent document; actual patent features should be reviewed for precise analysis).
